Ning‐Fang Ma

2.8k total citations · 1 hit paper
29 papers, 1.5k citations indexed

About

Ning‐Fang Ma is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ning‐Fang Ma has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Ning‐Fang Ma's work include RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (5 papers) and Reproductive Biology and Fertility (4 papers). Ning‐Fang Ma is often cited by papers focused on RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (5 papers) and Reproductive Biology and Fertility (4 papers). Ning‐Fang Ma collaborates with scholars based in China, Hong Kong and United States. Ning‐Fang Ma's co-authors include Xin‐Yuan Guan, Dan Xie, Liangping Xia, Feng Wang, Jing‐Ping Yun, Feng‐Wei Wang, Rixin Chen, Olivier Déas, Rui‐Hua Xu and Zhizhong Pan and has published in prestigious journals such as Nature Communications, Molecular and Cellular Biology and Hepatology.

In The Last Decade

Ning‐Fang Ma

29 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis

2019 537 citations Ning‐Fang Ma, Xin‐Yuan Guan et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ning‐Fang Ma China	14	1.1k	622	325	135	98	29	1.5k
Gaichao Zhao China	8	951 0.8×	445 0.7×	652 2.0×	177 1.3×	164 1.7×	13	1.5k
Rohit Mathur United States	18	998 0.9×	673 1.1×	293 0.9×	169 1.3×	83 0.8×	34	1.4k
Xiaojin Song China	17	1.6k 1.4×	1.3k 2.1×	441 1.4×	176 1.3×	221 2.3×	29	2.2k
Wen Zhou China	22	1.2k 1.0×	316 0.5×	427 1.3×	103 0.8×	82 0.8×	48	1.6k
Alejandro Parrales United States	13	698 0.6×	348 0.6×	463 1.4×	173 1.3×	110 1.1×	19	1.1k
Guanghui Zhang China	10	949 0.8×	458 0.7×	654 2.0×	191 1.4×	165 1.7×	15	1.5k
Linxiang Lan United Kingdom	14	685 0.6×	330 0.5×	272 0.8×	90 0.7×	71 0.7×	17	965
Ismail Hassan Ismail Canada	17	1.2k 1.1×	300 0.5×	441 1.4×	69 0.5×	143 1.5×	27	1.5k
Ling Cen United States	17	626 0.6×	197 0.3×	569 1.8×	251 1.9×	151 1.5×	44	1.3k
Prakash Radhakrishnan United States	21	986 0.9×	429 0.7×	549 1.7×	382 2.8×	89 0.9×	47	1.7k

Countries citing papers authored by Ning‐Fang Ma

Since Specialization

Citations

This map shows the geographic impact of Ning‐Fang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning‐Fang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning‐Fang Ma more than expected).

Fields of papers citing papers by Ning‐Fang Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning‐Fang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning‐Fang Ma. The network helps show where Ning‐Fang Ma may publish in the future.

Co-authorship network of co-authors of Ning‐Fang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Ning‐Fang Ma. A scholar is included among the top collaborators of Ning‐Fang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning‐Fang Ma. Ning‐Fang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Bingkun, Guiqing Zhou, Qian Peng, et al.. (2024). The synchronous upregulation of a specific protein cluster in the blood predicts both colorectal cancer risk and patient immune status. Gene. 930. 148842–148842. 1 indexed citations

Zhang, Chengyang, Xiaofeng Zhang, Yuanfeng Gong, et al.. (2023). Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery. Journal of Visualized Experiments. 1 indexed citations

Li, Meimei, Xiaofeng Zhang, Chengyang Zhang, et al.. (2022). Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma. STAR Protocols. 3(4). 101921–101921. 3 indexed citations

Tang, Yunqiang, Shaoyan Xi, Jane Ho Chun Loong, et al.. (2021). Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate. Science Translational Medicine. 13(579). 54 indexed citations

Cheng, Wei, Haolong Li, Shaoyan Xi, et al.. (2021). Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma. Nature Communications. 12(1). 7142–7142. 26 indexed citations

Guan, Xin‐Yuan, et al.. (2021). Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits. Experimental Hematology and Oncology. 10(1). 53–53. 10 indexed citations

Xiong, Xifeng, et al.. (2021). Diversity roles of CHD1L in normal cell function and tumorigenesis. Biomarker Research. 9(1). 16–16. 12 indexed citations

Zhang, Xiaofeng, Yinshan Bai, Li Huang, et al.. (2021). CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3. Cell Death and Disease. 12(10). 950–950. 18 indexed citations

Tang, Yunqiang, Yuanfeng Gong, Yue Zhao, et al.. (2020). Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model. Hepatology International. 14(4). 521–533. 4 indexed citations

10.

Li, Meimei, Yunqiang Tang, Yuanfeng Gong, et al.. (2019). Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma. BMC Cancer. 19(1). 851–851. 9 indexed citations

11.

Zhao, Xiaohui, Tian Xie, Ting Dai, et al.. (2018). CHP2 Promotes Cell Proliferation in Breast Cancer via Suppression of FOXO3a. Molecular Cancer Research. 16(10). 1512–1522. 14 indexed citations

12.

Bai, Yinshan, Cui Zhu, Hengxi Wei, et al.. (2018). Previously claimed male germline stem cells from porcine testis are actually progenitor Leydig cells. Stem Cell Research & Therapy. 9(1). 200–200. 4 indexed citations

13.

Zhu, Xiaolan, Li Huang, Jie Gong, et al.. (2017). NF-κB pathway link with ER stress-induced autophagy and apoptosis in cervical tumor cells. Cell Death Discovery. 3(1). 17059–17059. 54 indexed citations

14.

Dou, Dandan, Hao Zhao, Zili Li, et al.. (2017). CHD1L Promotes Neuronal Differentiation in Human Embryonic Stem Cells by Upregulating PAX6. Stem Cells and Development. 26(22). 1626–1636. 13 indexed citations

15.

Bai, Yinshan, et al.. (2016). Identification of CHD1L as an Important Regulator for Spermatogonial Stem Cell Survival and Self‐Renewal. Stem Cells International. 2016(1). 4069543–4069543. 9 indexed citations

16.

Bai, Yinshan, Shanshan Liu, Hengxi Wei, et al.. (2016). Differential gene expression in mouse spermatogonial stem cells and embryonic stem cells. International Journal of Molecular Medicine. 38(2). 423–432. 6 indexed citations

17.

Huang, Hongbiao, Shujue Li, Ningning Liu, et al.. (2010). Physiological levels of ATP negatively regulate proteasome function. Cell Research. 20(12). 1372–1385. 110 indexed citations

18.

Chua, Daniel T. T., Jonathan S. T. Sham, Minyue Zhang, et al.. (2009). Increased expression of annexin I is associated with drug‐resistance in nasopharyngeal carcinoma and other solid tumors. PROTEOMICS - CLINICAL APPLICATIONS. 3(6). 654–662. 16 indexed citations

19.

Yang, Huanjie, Ping Zhou, Hongbiao Huang, et al.. (2008). Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. International Journal of Cancer. 124(10). 2450–2459. 139 indexed citations

20.

Lau, S. H., Jonathan S. T. Sham, Dan Xie, et al.. (2005). Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene. 25(8). 1242–1250. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact